


Agomab Therapeutics Selected as One of Fierce Biotech’s “Fierce 15” Companies of 2022

Thabor Therapeutics appoints Jérémie Mariau as CEO

AdBio partners welcomes Inserm Transfert as investor in second fund – AFB Fund II

Ribonexus receives €2M in deep tech financing from Bpifrance
